SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $559,000 | +45.2% | 5,060 | -1.5% | 0.18% | +47.9% |
| Q2 2022 | $385,000 | -60.4% | 5,135 | -59.0% | 0.12% | -55.3% |
| Q2 2021 | $973,000 | +13.4% | 12,517 | +8.7% | 0.27% | +10.4% |
| Q1 2021 | $858,000 | -49.4% | 11,517 | +15.8% | 0.24% | -52.5% |
| Q4 2020 | $1,695,000 | -70.0% | 9,942 | -75.3% | 0.51% | -71.8% |
| Q3 2020 | $5,643,000 | +72.2% | 40,181 | +96.6% | 1.80% | +57.0% |
| Q2 2020 | $3,277,000 | +192.9% | 20,442 | +78.7% | 1.14% | +145.5% |
| Q1 2020 | $1,119,000 | -41.2% | 11,442 | -22.4% | 0.47% | -31.8% |
| Q4 2019 | $1,902,000 | +71.4% | 14,742 | 0.0% | 0.68% | +60.7% |
| Q3 2019 | $1,110,000 | -1.1% | 14,742 | +98.1% | 0.42% | -7.0% |
| Q2 2019 | $1,122,000 | +26.5% | 7,442 | 0.0% | 0.46% | +19.3% |
| Q1 2019 | $887,000 | +9.2% | 7,442 | 0.0% | 0.38% | -5.2% |
| Q4 2018 | $812,000 | – | 7,442 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
| Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
| Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
| Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
| Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
| Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
| ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
| Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
| Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
| GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |